Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Vanda Pharmaceuticals Inc. (VNDA) had Weighted-Average Shares Outstanding (Basic) of 60.23M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$50.53M |
|
$-62.51M |
|
$3.56M |
|
$46.97M |
|
$114.34M |
|
$-63.81M |
|
$1.43M |
|
$-62.38M |
|
$-62.38M |
|
$-62.51M |
|
$-62.51M |
|
$-62.51M |
|
$-62.51M |
|
$-63.81M |
|
$-60.14M |
|
|
Weighted-Average Shares Outstanding (Basic) |
60.23M |
60.23M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$264.48M |
|
$2.58M |
|
$147.98M |
|
$412.47M |
|
$164.03M |
|
$3.17M |
|
$28.26M |
|
$192.28M |
|
$220.19M |
|
$107.07M |
|
$220.19M |
|
60.45M |
|
| Cash Flow Statement Financials | |
$-81.29M |
|
$54.04M |
|
$-1.63M |
|
$85.32M |
|
$56.35M |
|
$-28.97M |
|
$4.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.61 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
92.95% |
|
-126.28% |
|
-126.28% |
|
-- |
|
-123.46% |
|
-123.72% |
|
$-81.70M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
2.12 |
|
0.85 |
|
106.32 |
|
-28.39% |
|
-58.39% |
|
-15.16% |
|
-27.99% |
|
$3.64 |
|
$-1.36 |
|
$-1.35 |
|